Cargando…

Fulminant myocarditis in COVID-19 and favorable outcomes with VA-ECMO

Detalles Bibliográficos
Autores principales:	Bhardwaj, Abhishek, Kirincich, Jason, Rampersad, Penelope, Soltesz, Edward, Krishnan, Sudhir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9040462/ https://www.ncbi.nlm.nih.gov/pubmed/35483495 http://dx.doi.org/10.1016/j.resuscitation.2022.04.021

Ejemplares similares

Case report: VA-ECMO for fulminant myocarditis in an infant with acute COVID-19
por: Hsu, Hao-Ting, et al.
Publicado: (2023)

Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support
por: Ramayya, Tarun, et al.
Publicado: (2022)

Reverse TakoTsubo or Fulminant myocarditis ? Life saving VA ECMO in a COVID 19 patient
por: Hamdan, Righab, et al.
Publicado: (2022)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

Postcardiotomy VA-ECMO for refractory cardiogenic shock
por: Charlesworth, Michael, et al.
Publicado: (2017)

Levosimendan for VA‐ECMO weaning: the silver lining
por: Kaddoura, Rasha, et al.
Publicado: (2021)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Wiwanitkit, Viroj
Publicado: (2020)

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021)

Cardiogenic Shock in COVID 19 Fulminant Myocarditis Treated with V-A ECMO
por: D'Errico Ramirez, A., et al.
Publicado: (2022)

Acute fulminant eosinophilic myocarditis due to Giardia lamblia infection
por: Beuy, Joob, et al.
Publicado: (2019)

Author's Reply to Heart Transplantation to Fulminant Myocarditis during COVID-19 Outbreak
por: Kim, In-Cheol, et al.
Publicado: (2020)

ECMO as an effective rescue therapeutic for fulminant myocarditis complicated with refractory cardiac arrest
por: Li, Ya-Ting, et al.
Publicado: (2017)

Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection()
por: Lozano Gómez, Herminia, et al.
Publicado: (2020)

SARS-CoV-2: a potential novel etiology of fulminant myocarditis
por: Chen, Chen, et al.
Publicado: (2020)

Successful treatment of intracardiac thrombosis in the presence of fulminant myocarditis requiring ECMO associated with COVID-19
por: Mejia, Erika J., et al.
Publicado: (2022)

Surgical pulmonary embolectomy on VA-ECMO
por: Steinhorn, Rachel, et al.
Publicado: (2021)

The first succesful extracorporeal membranous oxygenation treatment in a child with refractory fulminant myocarditis in Turkey
por: Anıl, Ayşe Berna, et al.
Publicado: (2016)

To: Fulminant myocarditis associated with the H1N1 influenza virus: case report and literature review
por: Joob, Beuy, et al.
Publicado: (2015)

Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir
por: Koenig, Tobias, et al.
Publicado: (2021)

Predicting clinical outcome in patients undergoing VA-ECMO
por: Kimmoun, Antoine, et al.
Publicado: (2019)

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Nursing effect of ECMO combined with CRRT in the treatment of fulminant myocarditis: A protocol of randomized controlled trial
por: Wu, Juan, et al.
Publicado: (2021)

Neonatal VA ECMO: Why and how?
por: Mendonca, Malaika
Publicado: (2017)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

Procedural volume and outcomes in patients undergoing VA-ECMO support
por: Becher, Peter Moritz, et al.
Publicado: (2020)

Extracorporeal life support survival in a pediatric hematopoietic cellular transplant recipient with presumed GvHD-related fulminant myocarditis
por: Zinter, M S, et al.
Publicado: (2017)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Microcirculatory assessment of patients under VA-ECMO
por: Kara, Atila, et al.
Publicado: (2016)

LV distention on VA-ECMO, what to do?
por: Pappalardo, Federico, et al.
Publicado: (2017)

Growing Evidence for LV Unloading in VA ECMO
por: Soltes, Jan, et al.
Publicado: (2023)

Fulminant myocarditis due to COVID-19
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

What is New in ECMO for COVID-19?
por: Furzan, Alberto, et al.
Publicado: (2023)

Concomitant use of veno-arterial extracorporeal membrane oxygenation and Impella in the intensive care unit: a case report of fulminant myocarditis with multi-organ failure
por: Gawda, Ryszard, et al.
Publicado: (2020)

Veno-Arterial Extracorporeal Membrane Oxygenation in Patients with Fulminant Myocarditis: A Review of Contemporary Literature
por: Venkataraman, Shreyas, et al.
Publicado: (2022)

Role of VA ECMO in septic shock: Does it work?
por: Combes, Alain
Publicado: (2017)

A case study of Harlequin syndrome in VA-ECMO
por: Al Hanshi, Said Ali Masoud, et al.
Publicado: (2017)

Recurrent Silicone Embolism Syndrome requiring VA ECMO
por: Madan, Nikhil, et al.
Publicado: (2022)

Hidden Harlequin syndrome in neonatal and pediatric VA-ECMO
por: Levy, Yael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ppdpl0qbpn1u6bgs5s0ftup6ar